ACT now: anti-malarial market complexity one decade after the introduction of artemisinin combination therapy – evidence from sub-Saharan Africa and the Greater Mekong Sub-region
Since 2002, national malaria control programmes in sub-Saharan Africa (SSA) and the Greater Mekong Sub-region (GMS) responded to increasing resistance of Plasmodium to existing drugs by adopting artemisinin-based combination therapy (ACT) as first-line treatment. From 2012, countries have increasingly adopted recommendations by the World Health Organization to confirm all suspected malaria cases with diagnostic testing. In 2015, several countries in the GMS made bold steps towards malaria elimination, in the context of evidence of a resurgence in resistance to first-line treatments. In sub-Saharan Africa, efforts continue to rationalize malaria case management and further reduce prevalence of the disease.
ACTwatch has been monitoring anti-malarial and diagnostic markets since 2008. Standardized methods allow for comparability across survey rounds and over time, and provide evidence to inform policies, strategies and funding decisions. This series provides a comprehensive contemporary view of anti-malarial markets across several countries in SSA and the GMS, examining current levels of access to quality-assured first-line treatments and malaria diagnostics, and documenting the persistence of other non-first line medicines. This evidence serves as a benchmark for public and private sector initiatives that have aimed to scale up access to first-line treatment and confirmatory testing. Evidence can guide future strategies aimed at improving malaria case management and for accelerating progress towards malaria elimination.
- RESEARCH
Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies
Understanding Cambodia’s anti-malarial and diagnostic landscape in 2015 is critical for informing and monitoring strategies and policies as Cambodia moves forward with national efforts to eliminate malaria. Th...Malaria Journal 2017 16:171Published on: 25 April 2017 - RESEARCH
Anti-malarial landscape in Myanmar: results from a nationally representative survey among community health workers and the private sector outlets in 2015/2016
In 2015/2016, an ACTwatch outlet survey was implemented to assess the anti-malarial and malaria testing landscape in Myanmar across four domains (Eastern, Central, Coastal, Western regions). Indicators provide...Malaria Journal 2017 16:129Published on: 25 April 2017 - RESEARCH
The malaria testing and treatment landscape in the southern Lao People’s Democratic Republic (PDR)
In the context of national and regional goals to eliminate malaria by 2030, the Center for Malaria Parasitology and Entomology in the Lao PDR is implementing strategies to ensure all malaria cases are detected...Malaria Journal 2017 16:169Published on: 25 April 2017 - RESEARCH
Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey
The containment of artemisinin resistance in Myanmar, historically an important probable origin and route of anti-malarial resistance to the India sub-continent and beyond, is crucial to global malaria control...Malaria Journal 2017 16:170Published on: 25 April 2017 - COMMENTARY
Watching the availability and use of rapid diagnostic tests (RDTs) and artemisinin-based combination therapy (ACT)
At the turn of this new century and after much debate, the malaria community reckoned with failing first line therapies and moved to a global recommendation for deployment of an artemisinin-based combination t...Malaria Journal 2017 16:165Published on: 24 April 2017 - RESEARCH
The malaria testing and treatment market in Kinshasa, Democratic Republic of the Congo, 2013
The Democratic Republic of Congo (DRC) is one of the two most leading contributors to the global burden of disease due to malaria. This paper describes the malaria testing and treatment market in the nation’s ...Malaria Journal 2017 16:94Published on: 28 February 2017
.png)
No hay comentarios:
Publicar un comentario